Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Theravance Inc (NASDAQ:THRX)

14.16
Delayed Data
As of 3:55pm ET
 +0.335 / +2.42%
Today’s Change
10.58
Today|||52-Week Range
23.84
+0.04%
Year-to-Date

Today’s Trading

Previous close13.82
Today’s open14.17
Day’s range13.95 - 14.60
Volume855,959
Average volume (3 months)561,234
Market cap$1.6B
Dividend yield7.06%
Data as of 3:55pm ET, 08/31/2015

Growth & Valuation

Earnings growth (last year)+10.18%
Earnings growth (this year)+87.60%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+309.82%
P/E ratioNM
Price/Sales81.32
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.14-3.57%
IRWDIronwood Pharmaceuti...-0.23-2.09%
TTPHTetraphase Pharmaceu...-0.42-0.96%
INSMInsmed Inc-1.15-4.48%
Data as of 3:55pm ET, 08/31/2015

Financials

Next reporting dateOctober 22, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$19.5M
Annual profit (last year)-$168.5M
Net profit margin-377.10%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers